Blood Level of Tacrolimus in Patients with Severe Allergic Conjunctivitis Treated by 0.1% Tacrolimus Ophthalmic Suspension

Blood Level of Tacrolimus in Patients with Severe Allergic Conjunctivitis Treated by 0.1% Tacrolimus Ophthalmic Suspension

Background: To estimate the efficacy and safety of 0.1% tacrolimus ophthalmic suspension based on the blood level of tacrolimus in patients with severe allergic conjunctivitis. Methods: Fifty-two patients in whom topical anti-allergic agents had been ineffective were treated with 0.1% tacrolimus oph...

Full description

Bibliographic Details
Main Authors: Nobuyuki Ebihara, Yuichi Ohashi, Hiroshi Fujishima, Atsuki Fukushima, Yayoi Nakagawa, Kenichi Namba, Shigeki Okamoto, Jun Shoji, Etsuko Takamura, Eiichi Uchio, Dai Miyazaki
Format: Article
Language:English
Published: Elsevier 2012-01-01
Series:Allergology International
Subjects:
allergic conjunctivitis
blood level
efficacy
safety evaluation
tacrolimus
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015302215

Internet

http://www.sciencedirect.com/science/article/pii/S1323893015302215

Similar Items